Sangamo Therapeutics
SGMO
#9880
Rank
HK$0.43 B
Marketcap
HK$1.04
Share price
-5.46%
Change (1 day)
-69.61%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -HK$0.85 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are HK$32.87 Million. In 2024 the company made an earning of -HK$0.78 Billion, an increase over its 2023 earnings that were of -HK$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.85 Billion10.16%
2024 -HK$0.78 Billion-17.27%
2023 -HK$0.94 Billion-40.88%
2022 -HK$1.58 Billion9.79%
2021 -HK$1.44 Billion41.52%
2020 -HK$1.02 Billion23.17%
2019 -HK$0.83 Billion36.33%
2018 -HK$0.61 Billion36.89%
2017 -HK$0.45 Billion-22.32%
2016 -HK$0.57 Billion54.86%
2015 -HK$0.37 Billion75.62%
2014 -HK$0.21 Billion0.13%
2013 -HK$0.21 Billion
2011 -HK$0.29 Billion43.66%
2010 -HK$0.2 Billion28.52%
2009 -HK$0.16 Billion-23.55%
2008 -HK$0.2 Billion2.45%
2007 -HK$0.2 Billion19.5%
2006 -HK$0.17 Billion50.78%
2005 -HK$0.11 Billion75%
2004 -HK$61.51 Million-33.25%
2003 -HK$92.15 Million-62.27%
2002 -HK$0.25 Billion102.82%
2001 -HK$0.13 Billion23.21%
2000 -HK$97.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.39 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.14 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$12.70 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-HK$19.79 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.70 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$102.97 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.80 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.01 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA